DRAXIMAGE XENON XE 133 DIN 02360268
Status: Cancelled Post Market
Holder: JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Molecule: XENON
Health Canada record
| Active ingredient(s) | XENON 133 XE 370 MBq |
|---|---|
| Dosage form | Gas |
| Route | Inhalation |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 27-Oct-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jubilant Draximage Inc. dba Jubilant Radiopharma — licence 101869, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing XENON
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02360276 | DRAXIMAGE XENON XE 133 | JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA | Gas | XENON 133 XE 740 MBq | Cancelled Post Market |
| 02327880 | XENON | LANTHEUS MI CANADA INC | Gas | XENON 133 XE 10 MCI | Cancelled Pre Market |
| 02327899 | XENON | LANTHEUS MI CANADA INC | Gas | XENON 133 XE 20 MCI | Cancelled Pre Market |
| 02014386 | XENON OXYGEN USP MEDICAL GAS MIXTURE | PRAXAIR CANADA INC | Gas | XENON 133 XE 35 %; OXYGEN 65 % | Cancelled Post Market |
| 02328747 | XENON XE-133 GAS | BRISTOL-MYERS SQUIBB CANADA | Gas | XENON 133 XE 150 MCI | Cancelled Pre Market |
International API supply for XENON
3 active FDA Drug Master Files.
Request a quote for DRAXIMAGE XENON XE 133